Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Takeda seeks German approval for idebenone

June 28, 1996

Ampalex proves effective and safe

June 28, 1996

Protein kinase inhibitors reported by Cephalon

June 28, 1996

FDA approves drug/device combination

June 28, 1996

FDA clears Myotrophin early access program

June 28, 1996

MACH discovered by Weizmann Institute

June 28, 1996

Gabitril approved in France as add-on therapy

June 28, 1996

Depakote receives FDA approval for new indication

June 28, 1996

Gensia's GP-3269 in phase I

June 28, 1996

TV-1901 demonstrates efficiency and safety

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...